Evidence map›Paper›PMID 35884876›Full record

ArticleBiomedicines2022

Antidepressive-like Behavior-Related Metabolomic Signatures of Sigma-1 Receptor Knockout Mice.

Baiba Svalbe, Baiba Zvejniece, Gundega Stelfa, Karlis Vilks, Edijs Vavers, José Miguel Vela, Maija Dambrova, Liga Zvejniece

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Sigma-1 receptor and seizures.Pharmacological research · 2023
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Baiba SvalbeLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.ORCID 0000-0001-8390-773X
Baiba ZvejnieceLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.
Gundega StelfaLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.
Karlis VilksLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.ORCID 0000-0002-4203-2129
Edijs VaversLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.ORCID 0000-0003-1322-1307
José Miguel VelaWelab Barcelona, Barcelona Science Park (PCB), Baldiri Reixac 4-8, 08028 Barcelona, Spain.ORCID 0000-0002-6809-1477
Maija DambrovaLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.ORCID 0000-0002-1739-0928
Liga ZvejnieceLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Aizkraukles Street 21, LV-1006 Riga, Latvia.
Latvijas Organiskās Sintēzes Institūts · LVLatvia University of Life Sciences and Technologies · LV

Funding

The European Regional Development Fund (ERDF) 1.1.1.2/VIAA/1/16/244
6 · The paper itself

Abstract

Sigma-1 receptor (Sig1R) has been proposed as a therapeutic target for neurological, neurodegenerative, and psychiatric disorders, including depression and anxiety. Identifying metabolites that are affected by Sig1R absence and cross-referencing them with specific mood-related behaviors would be helpful for the development of new therapies for Sig1R-associated disorders. Here, we examined metabolic profiles in the blood and brains of male CD-1 background Sig1R knockout (KO) mice in adulthood and old age and correlated them with the assessment of depression- and anxiety-related behaviors. The most pronounced changes in the metabolic profile were observed in the plasma of adult Sig1R KO mice. In adult mice, the absence of Sig1R significantly influenced the amino acid, sphingolipid (sphingomyelin and ceramide (18:1)), and serotonin metabolic pathways. There were higher serotonin levels in plasma and brain tissue and higher histamine levels in the plasma of Sig1R KO mice than in their age-matched wild-type counterparts. This increase correlated with the reduced behavioral despair in the tail suspension test and lack of anhedonia in the sucrose preference test. Overall, these results suggest that Sig1R regulates behavior by altering serotonergic and histaminergic systems and the sphingolipid metabolic pathway.

Indexed as

ceramidedespair behaviormetabolomic signaturesserotoninsigma-1 receptor

Identifiers

PMID35884876
PMCPMC9313356
OpenAlexW4283777684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.